NCFG
WST icon

New Century Financial Group’s West Pharmaceutical WST Stock Holding History

New Century Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,071
Closed -$240K – 175
2025
Q1 		$240K Buy
1,071
+85
+9% +$23.4K 0.28% 112
2024
Q4 		$331K Sell
986
-23
-2% -$7.24K 0.14% 194
2024
Q3 		$303K Buy
1,009
+1
+0.1% +$306 0.11% 228
2024
Q2 		$332K Buy
1,008
+296
+42% +$105K 0.14% 185
2024
Q1 		$282K Buy
712
+8
+1% +$2.96K 0.2% 135
2023
Q4 		$248K Buy
+704
New +$249K 0.21% 135

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

New Century Financial Group's WST Position: Q2 2025 in Review

New Century Financial Group sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 1,071 shares — an estimated $240K sold.

New Century Financial Group first reported a position in WST in Q4 2023 and held it in 6 quarters. The position peaked at $332K in Q2 2024. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

  • New Century Financial Group reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • New Century Financial Group sold 1,071 West Pharmaceutical shares in Q2 2025, an estimated $240K.
  • New Century Financial Group first reported a position in West Pharmaceutical in Q4 2023 and held it in 6 quarters.
  • New Century Financial Group's West Pharmaceutical position peaked at $332K in Q2 2024.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on New Century Financial Group's 13F filing for Q2 2025, filed 21 Jul 2025.